Material selection is one of the earliest decisions that can determine whether a medical device succeeds in clinical use, manufacturing, and validation. Teams planning precision injection molding for medical applications must consider much more than a resin’s price, color, or appearance. The selected material may affect patient safety, part durability, tooling design, assembly methods, sterilization, and the evidence needed to support market readiness.
A polymer that performs well in a quick prototype is not automatically suitable for production. It may warp during molding, crack after repeated cleaning, react poorly to chemicals, or lose performance after sterilization. The right choice begins with the full range of tasks the finished device must perform, from packaging and shipping through its final use and disposal.
Why Material Choice Matters Early
Every material decision influences later development work. A change in resin can alter shrinkage, mold fill, cycle time, bonding performance, and the dimensions of mating parts. It can also require teams to revisit verification testing, aging studies, supplier documentation, and risk assessments. Making the decision early gives engineering, quality, sourcing, and manufacturing teams time to identify tradeoffs before design changes become expensive.
Consider a handheld surgical instrument. Its housing may need stiffness to protect internal components, a textured surface for a secure grip, resistance to disinfectants, and stable performance after many cleaning cycles. Choosing solely for strength could produce a rigid part that becomes brittle with repeated use. Choosing only for appearance could create a material that does not hold tight tolerances.
Define Real-World Device Demands
Start with a requirements list that describes how each component will function in the finished device. The FDA evaluates biocompatibility in the context of the final device, including its materials, processing, clinical use, and body contact. Its guidance on biocompatibility assessment is a useful reminder that a material cannot be evaluated in isolation.

- Define the function. Determine whether the component is structural, flexible, fluid-facing, protective, sealing, or cosmetic.
- Identify body contact. Record whether it contacts skin, tissue, blood, medication, or another device component.
- Measure exposure. Distinguish brief contact from repeated, prolonged, or permanent exposure.
- List conditions. Include temperature, pressure, moisture, impact, motion, chemicals, and storage conditions.
- Set the service life. Clarify whether the device is single-use, reusable, or intended for long-term use.
Safety and Biocompatibility Questions
“Medical grade” can be a useful starting point, but it is not a blanket approval for every application. The finished device may include colorants, fillers, coatings, adhesives, lubricants, processing aids, and residues that change the safety picture. Sterilization and aging can also affect the final composition or surface condition.
Ask practical questions early. Could substances migrate from the part? Could heat, radiation, cleaning agents, or processing change its properties? Does the material have a documented history in a similar use? Are chemical characterization, toxicological review, or biological testing needed? A risk-based review should examine the completed device, not merely the base polymer’s name on a data sheet.
Performance Factors to Compare
No material is best in every category. Compare candidates against the actual requirements rather than relying on a short list of familiar resins.
- Strength and stiffness: Can the part resist cracking, bending, or deformation under expected loads?
- Impact and fatigue resistance: Can it survive drops, shipping, repeated actuation, or cyclic stress?
- Chemical resistance: Will drugs, bodily fluids, disinfectants, oils, or cleaning solutions affect it?
- Dimensional stability: Will heat or humidity change the part enough to interfere with assembly?
- Surface performance: Does the component need low friction, a reliable seal, grip, clarity, or patient comfort?
Plan for Sterilization and Cleaning
Sterilization should be part of material selection, not a final production detail. Heat, steam, radiation, gas exposure, and chemical cleaning can cause discoloration, warpage, embrittlement, loss of strength, or changes at interfaces between materials. Seals, moving components, adhesives, and overmolded features deserve particular attention.
For reusable devices, test finished parts after the expected number of cleaning and sterilization cycles. A surgical handle may pass an initial mechanical test but fail after months of real-world reprocessing. Packaging, shelf life, and storage temperature should also be included in the performance plan.
Check the Manufacturing Fit
A material can meet functional targets yet still create manufacturing problems. Review whether it will fill thin sections, reproduce small details, maintain tight tolerances, and work with the planned molding, machining, bonding, or assembly process. Consider drying requirements, shrinkage, warpage, weld lines, gate placement, wall thickness, draft angles, ribs, and bosses before finalizing tooling.
Questions for Production Teams
- Can the process deliver consistent results at the planned production volume?
- Will the material create excessive scrap, long cycle times, or inspection demands?
- Could small design adjustments reduce the risk of molding before validation begins?
Look Beyond the Initial Material Cost
Price per pound is only one part of the decision. A lower-cost resin may require special handling, generate more scrap, extend cycle times, or create assembly challenges. A more expensive option may produce stable parts with less rework and lower inspection costs. Compare the total cost of ownership, including tooling, labor, yield, testing, supply continuity, and the impact of delays or field failures.
Teams should also assess lead times, regional availability, qualified alternate sources, and the consequences of supplier formulation changes. Industry coverage of medical plastics developments can help teams monitor shifts in materials, processing, and supply conditions that may affect future sourcing plans.
Build a Testing and Documentation Plan
Document the exact material grade, supplier, formulation, additives, colorants, coatings, processing method, and sterilization approach. Set measurable performance targets aligned with the intended use, then determine which physical, chemical, biological, and aging studies are appropriate. Supplier certificates provide useful evidence, but they do not replace the assessment of the final part.
Formal change control is essential. Any significant change in resin, colorant, supplier, processing window, or sterilization method should prompt a review to determine whether additional testing is necessary. Clear records make later investigations faster and reduce uncertainty during quality or regulatory reviews.
Common Material Selection Mistakes
- Choosing a familiar material without confirming it suits the new device and use conditions.
- Focusing on strength while overlooking chemical resistance, friction, or biological considerations.
- Ignoring the effects of molding, bonding, cleaning, sterilization, and aging.
- Assuming similar grades or suppliers have identical formulations and performance.
- Waiting until late development to test the finished device under realistic conditions.
A Practical Material Selection Checklist
- Device function, body contact, and exposure duration are clearly defined.
- Mechanical, chemical, dimensional, and surface requirements are documented.
- Sterilization, cleaning, packaging, and storage conditions are known.
- The manufacturing process and expected production volume are evaluated.
- Material composition, supplier records, and alternate-source risks are reviewed.
- Testing reflects the final device and expected production process.
- Material changes are controlled through documented review and retesting decisions.
Final Takeaway
Material selection is a device decision, not simply a purchasing decision. The strongest choice balances safety, performance, manufacturability, validation needs, supply stability, and long-term cost. When teams evaluate those factors early, they can move from concept to dependable clinical use with fewer redesigns, fewer production surprises, and greater confidence in the finished device.